Risk factors for primary graft dysfunction after lung transplantation

Bryan A. Whitson, Dilip S. Nath, Adam Johnson, +5

Journal of Thoracic and Cardiovascular Surgery

TransplantationMedicineOutcomes ResearchGraft SurvivalSurgery +2

Validation of the Proposed International Society for Heart and Lung Transplantation Grading System for Primary Graft Dysfunction After Lung Transplantation

Matthew E. Prekker, Dilip S. Nath, Adam Walker, +5

The Journal of Heart and Lung Transplantation

Heart FailureTransplantationPrimary Graft DysfunctionMedicineOutcomes Research +5

A functional genomics approach reveals novel quantitative trait loci associated with platelet signaling pathways

Chris I. Jones, Sarah Bray, Stephen F. Garner, +22

Blood

Functional genomics in zebrafish permits rapid characterization of novel platelet membrane proteins

Marie O’Connor, Isabelle I. Salles, Ana Cvejic, +14

Blood

Anti-serum albumin domain antibodies in the development of highly potent, efficacious and long-acting interferon

Adam Walker, Gráinne Dunlevy, D. Rycroft, +8

Protein Engineering Design and Selection

ImmunologyPathologyImmunotherapySynthetic ImmunologyInflammation +14

Differential Inhibition of Human Atherosclerotic Plaque–Induced Platelet Activation by Dimeric GPVI-Fc and Anti-GPVI Antibodies

Janina Jamasbi, Remco T. A. Megens, Mariaelvy Bianchini, +12

Journal of the American College of Cardiology

Ethanol‐glycine irrigating fluid for transurethral resection of the prostate in practice

A.A. Okeke, Richard Lodge, Alice Hinchliffe, +3

British Journal of Urology

Novel Bispecific Domain Antibody to LRP6 Inhibits Wnt and R-spondin Ligand-Induced Wnt Signaling and Tumor Growth

Heather L. Jackson, David Granger, Gavin C. Jones, +11

Molecular Cancer Research

Liver-Targeting of Interferon-Alpha with Tissue-Specific Domain Antibodies

Edward Coulstock, Jane Sosabowski, Milan Ovečka, +9

PLoS ONE

Liver FibrosisImmunologyImmune RegulationPathologyImmunologic Mechanism +24

Novel Interaction Mechanism of a Domain Antibody-based Inhibitor of Human Vascular Endothelial Growth Factor with Greater Potency than Ranibizumab and Bevacizumab and Improved Capacity over Aflibercept

Adam Walker, Chun‐wa Chung, Margarete Neu, +11

Journal of Biological Chemistry

InflammationNovel Interaction MechanismAngiogenesisMedicineVascular Endothelial Growth Factor +8